Found: 51
Select item for more details and to access through your institution.
Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 15, p. 156, doi. 10.1111/bjh.15405
- By:
- Publication type:
- Article
Biological Features of Nanoparticles: Protein Corona Formation and Interaction with the Immune System.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 12, p. 2605, doi. 10.3390/pharmaceutics14122605
- By:
- Publication type:
- Article
Nanocarriers as a Delivery Platform for Anticancer Treatment: Biological Limits and Perspectives in B-Cell Malignancies.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/pharmaceutics14091965
- By:
- Publication type:
- Article
Chitosan-Based Biocompatible Copolymers for Thermoresponsive Drug Delivery Systems: On the Development of a Standardization System.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 11, p. 1876, doi. 10.3390/pharmaceutics13111876
- By:
- Publication type:
- Article
Thermoresponsive Chitosan-Grafted-Poly(N -vinylcaprolactam) Microgels via Ionotropic Gelation for Oncological Applications.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 10, p. 1654, doi. 10.3390/pharmaceutics13101654
- By:
- Publication type:
- Article
Nanoparticles-Based Oligonucleotides Delivery in Cancer: Role of Zebrafish as Animal Model.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 8, p. 1106, doi. 10.3390/pharmaceutics13081106
- By:
- Publication type:
- Article
The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target.
- Published in:
- Journal of Oncology, 2020, p. 1, doi. 10.1155/2020/4638192
- By:
- Publication type:
- Article
Activation-Induced Cytidine Deaminase and CD38 Expression in B-Cell Chronic Lymphocytic Leukemia.
- Published in:
- Clinical Lymphoma & Myeloma, 2005, v. 6, n. 3, p. 251
- By:
- Publication type:
- Article
The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 18, p. N.PAG, doi. 10.3390/ijms231810279
- By:
- Publication type:
- Article
Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 17, p. 10038, doi. 10.3390/ijms231710038
- By:
- Publication type:
- Article
A Novel Epigenetic Machine Learning Model to Define Risk of Progression for Hepatocellular Carcinoma Patients.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 3, p. 1075, doi. 10.3390/ijms22031075
- By:
- Publication type:
- Article
Targeted therapy for multiple myeloma: an overview on CD138-based strategies.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1370854
- By:
- Publication type:
- Article
Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 1, p. 156, doi. 10.1111/bjh.15405
- By:
- Publication type:
- Article
Expression of the transcribed ultraconserved region 70 and the related long non‐coding RNA AC092652.2‐202 has prognostic value in Chronic Lymphocytic Leukaemia.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 6, p. 1045, doi. 10.1111/bjh.15237
- By:
- Publication type:
- Article
NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation types.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 4, p. 597, doi. 10.1111/bjh.14843
- By:
- Publication type:
- Article
Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4387, doi. 10.3390/cancers13174387
- By:
- Publication type:
- Article
Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1668, doi. 10.3390/cancers12061668
- By:
- Publication type:
- Article
A Novel Comprehensive Clinical Stratification Model to Refine Prognosis of Glioblastoma Patients Undergoing Surgical Resection.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 386, doi. 10.3390/cancers12020386
- By:
- Publication type:
- Article
A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine Learning.
- Published in:
- Cancers, 2019, v. 11, n. 10, p. 1562, doi. 10.3390/cancers11101562
- By:
- Publication type:
- Article
New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma.
- Published in:
- Cancers, 2019, v. 11, n. 8, p. 1086, doi. 10.3390/cancers11081086
- By:
- Publication type:
- Article
The Molecular and Microenvironmental Landscape of Glioblastomas: Implications for the Novel Treatment Choices.
- Published in:
- Frontiers in Neuroscience, 2020, v. 14, p. N.PAG, doi. 10.3389/fnins.2020.603647
- By:
- Publication type:
- Article
Targeted chitosan nanobubbles as a strategy to down-regulate microRNA-17 into B-cell lymphoma models.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1200310
- By:
- Publication type:
- Article
A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04745-9
- By:
- Publication type:
- Article
Machine learning to improve interpretability of clinical, radiological and panel-based genomic data of glioma grade 4 patients undergoing surgical resection.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04308-y
- By:
- Publication type:
- Article
Regulation of HIF-1 α in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role as a Therapeutic Target.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S214, doi. 10.1016/j.clml.2018.07.076
- By:
- Publication type:
- Article
Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 3, p. 652, doi. 10.1002/cpt.2960
- By:
- Publication type:
- Article
Machine Learning Application in a Phase I Clinical Trial Allows for the Identification of Clinical‐Biomolecular Markers Significantly Associated With Toxicity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 3, p. 686, doi. 10.1002/cpt.2511
- By:
- Publication type:
- Article
Characterization of Thermoresponsive Poly-N-Vinylcaprolactam Polymers for Biological Applications.
- Published in:
- Polymers (20734360), 2021, v. 13, n. 16, p. 2639, doi. 10.3390/polym13162639
- By:
- Publication type:
- Article
Loss of Spry1 reduces growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 5, p. 1, doi. 10.1038/s41419-020-2585-y
- By:
- Publication type:
- Article
Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells.
- Published in:
- Journal of Translational Medicine, 2010, v. 8, p. 23, doi. 10.1186/1479-5876-8-23
- By:
- Publication type:
- Article
Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Surface-antigen expression profiling of B cell chronic lymphocytic leukemia: from the signature of specific disease subsets to the identification of markers with prognostic relevance.
- Published in:
- Journal of Translational Medicine, 2006, v. 4, p. 11, doi. 10.1186/1479-5876-4-11
- By:
- Publication type:
- Article
A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia.
- Published in:
- Journal of Cellular Physiology, 2006, v. 207, n. 2, p. 354, doi. 10.1002/jcp.20570
- By:
- Publication type:
- Article
Signature of B-CLL with different prognosis by Shrunken centroids of surface antigen expression profiling.
- Published in:
- Journal of Cellular Physiology, 2005, v. 204, n. 1, p. 113, doi. 10.1002/jcp.20269
- By:
- Publication type:
- Article
13q14 Deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia.
- Published in:
- Genes, Chromosomes & Cancer, 2011, v. 50, n. 8, p. 633, doi. 10.1002/gcc.20885
- By:
- Publication type:
- Article
Low-dose radiotherapy in diffuse large B-cell lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Zebrafish: A Useful Animal Model for the Characterization of Drug-Loaded Polymeric NPs.
- Published in:
- Biomedicines, 2022, v. 10, n. 9, p. 2252, doi. 10.3390/biomedicines10092252
- By:
- Publication type:
- Article
A New Epigenetic Model to Stratify Glioma Patients According to Their Immunosuppressive State.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 3, p. 576, doi. 10.3390/cells10030576
- By:
- Publication type:
- Article
Machine learning in onco-pharmacogenomics: a path to precision medicine with many challenges.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2023.1260276
- By:
- Publication type:
- Article
A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1274088
- By:
- Publication type:
- Article
Potential therapeutic role of antagomiR17 for the treatment of chronic lymphocytic leukemia.
- Published in:
- Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 1, doi. 10.1186/s13045-014-0079-z
- By:
- Publication type:
- Article
Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 3, doi. 10.1186/1756-8722-6-83
- By:
- Publication type:
- Article
ARHGDIA, a mutant TP53-associated Rho GDP dissociation inhibitor, is over-expressed in gene expression profiles of TP53 disrupted chronic lymphocytic leukaemia cells.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 4, p. 596, doi. 10.1111/bjh.12258
- By:
- Publication type:
- Article
Clinical significance of c.7544-7545 del CT NOTCH1 mutation in chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 3, p. 415, doi. 10.1111/bjh.12128
- By:
- Publication type:
- Article
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage.
- Published in:
- British Journal of Haematology, 2011, v. 153, n. 1, p. 3, doi. 10.1111/j.1365-2141.2010.08440.x
- By:
- Publication type:
- Article
MDM4 (MDMX) is overexpressed in chronic lymphocytic leukaemia (CLL) and marks a subset of p53<sup>wild-type</sup> CLL with a poor cytotoxic response to Nutlin-3.
- Published in:
- 2010
- By:
- Publication type:
- Letter
IGHD3-3 fails to behave as unfavourable prognostic marker in chronic lymphocytic leukaemia.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
- Published in:
- British Journal of Haematology, 2009, v. 144, n. 4, p. 492, doi. 10.1111/j.1365-2141.2008.07469.x
- By:
- Publication type:
- Article
Analysis of IgV<sub>H</sub> gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery.
- Published in:
- British Journal of Haematology, 2004, v. 126, n. 1, p. 29, doi. 10.1111/j.1365-2141.2004.04985.x
- By:
- Publication type:
- Article
Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticles.
- Published in:
- Journal of Nanobiotechnology, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12951-023-02134-4
- By:
- Publication type:
- Article